the Genco Commodus. During the three and six months ended June 30, 2023, the Company did not complete the sale of any vessels. Refer to Note 4 — Vessel Acquisitions and Dispositions for further detail regarding the sale of these vessels.
Other operating expense
Other operating expense of $3,924 and $5,728 recorded during the three and six months ended June 30, 2024, respectively, consist of costs incremental to routine expenses that were incurred related to the Company’s 2024 annual meeting held on May 23, 2024.
3 – CASH FLOW INFORMATION
For the six months ended June 30, 2024, the Company had non-cash investing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expenses consisting of $702 for the Purchase of vessels and ballast water treatment systems, including deposits, $373 for the Purchase of other fixed assets, $39 for Vessels held for sale and $75 for the Net proceeds from sale of vessels. For the six months ended June 30, 2024, the Company had non-cash financing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expense consisting of $1,230 for Cash dividends payable.
For the six months ended June 30, 2023, the Company had non-cash investing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expenses consisting of $749 for the Purchase of vessels and ballast water treatment systems, including deposits, and $301 for the Purchase of other fixed assets. For the six months ended June 30, 2023, the Company had non-cash financing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expense consisting of $853 for Cash dividends payable.
During the six months ended June 30, 2024 and 2023, cash paid for interest was $7,071 and $6,641, respectively, which was offset by $588 and $3,443 received as result of the interest rate cap agreements, respectively.
During the six months ended June 30, 2024 and 2023, any cash paid for income taxes was insignificant.
All stock options exercised during the six months ended June 30, 2024 and 2023 were cashless. Refer to Note 13 — Stock-Based Compensation for further information.
On May 23, 2024, the Company granted 38,122 restricted stock units to certain members of the Board of Directors. The aggregate fair value of these restricted stock units was $825.
On February 21, 2024, the Company granted 168,411 restricted stock units and 99,065 performance-based restricted stock units to certain individuals. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $3,060 and $2,143, respectively.
On June 16, 2023, the Company granted 3,917 restricted stock units and 3,917 performance-based restricted stock units to an individual. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $56 and $64, respectively.
On May 16, 2023, the Company granted 43,729 restricted stock units to certain members of the Board of Directors. The aggregate fair value of these restricted stock units was $600.
On April 14, 2023, the Company granted 75,920 restricted stock units and 75,920 performance-based restricted stock units to certain individuals. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $1,237 and $1,451, respectively.
On April 3, 2023, the Company granted 1,630 restricted stock units to an individual. The aggregate fair value of these restricted stock units was $25.